Patent ID: 11866507
Assignee: INHIBRX, INC.
Field: Biotechnology (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 1:
2. The multispecific polypeptide construct of claim 1, wherein the TAA is selected from the group consisting of 5T4, B7H3, Carbonic anhydrase 9, CD3, CD20, CD38, CD47, CEACAM5 (CEA), cMet, CXCL10, CXCR4, DLL3, EGFR, Folate receptor alpha (FRα), HER2, HGF, IL-6R, IL-23, Mesothelin, MUC1, PD-1, PD-L1, PSMA, TAG-72, TIM-3, Tumor necrosis factor alpha (TNFα), VCAM-1, and VEGFR2.